Adicet Bio, Inc. (ACET) Stock Overview
Explore Adicet Bio, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Adicet Bio, Inc. (ACET)
Key Financials
Key Financials
Market Cap
83.5M
P/E Ratio
-0.78
EPS (TTM)
$-11.45
ROE
-0.75%
ACET Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Adicet Bio, Inc. (NASDAQ: ACET) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Adicet Bio, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ACET on the NASDAQ shows an RSI of 47.68, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $9.59 for the NASDAQ listing.
Key metrics behind Adicet Bio, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.78 and a market capitalization of 83.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ACET on the NASDAQ.